Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

General Drug Use-results Survey on PROPESS® Vaginal Inserts 10 mg in Treatment for Initiation of Cervical Ripening in Patients at Term (From 37 Completed Weeks of Gestation)

NCT04773314 is registered in ClinicalTrials.gov with Ferring Pharmaceuticals as lead sponsor.

NCT NCT04773314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04773314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
General Drug Use-results Survey on PROPESS® Vaginal Inserts 10 mg in Treatment for Initiation of Cervical Ripening in Patients at Term (From 37 Completed Weeks of Gestation)
Lead sponsor
Ferring Pharmaceuticals
Phase
Observational
Overall status
Completed
Start date
February 28, 2021
Completion date
June 30, 2022
Enrollment
409 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical ripening, pregnancy